Javier Sabater

2.4k total citations
22 papers, 102 citations indexed

About

Javier Sabater is a scholar working on Oncology, Economics and Econometrics and Immunology. According to data from OpenAlex, Javier Sabater has authored 22 papers receiving a total of 102 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Economics and Econometrics and 5 papers in Immunology. Recurrent topics in Javier Sabater's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), CAR-T cell therapy research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Javier Sabater is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), CAR-T cell therapy research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Javier Sabater collaborates with scholars based in United States, United Kingdom and France. Javier Sabater's co-authors include Michael B. Atkins, Komal Gupte-Singh, Sumati Rao, David F. McDermott, Meredith M. Regan, Rhys Pockett, Hayley Bennett, Phil McEwan, Karin Sennfält and Keshwar Baboolal and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Annals of the Rheumatic Diseases.

In The Last Decade

Javier Sabater

19 papers receiving 101 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Sabater United States 5 61 39 13 13 13 22 102
Scott Ramsey United States 6 48 0.8× 27 0.7× 13 1.0× 12 0.9× 12 158
Miriam O’Connor Ireland 7 44 0.7× 24 0.6× 10 0.8× 20 1.5× 19 117
Aneta Suder United Kingdom 5 51 0.8× 27 0.7× 8 0.6× 29 2.2× 1 0.1× 13 116
Dominic Agius France 4 95 1.6× 18 0.5× 10 0.8× 8 0.6× 5 143
Gracemarie Bricalli Israel 4 34 0.6× 37 0.9× 6 0.5× 8 0.6× 5 106
Pankaj Mistry United Kingdom 7 73 1.2× 13 0.3× 20 1.5× 22 1.7× 18 166
Francisco J. Orlandi Brazil 4 59 1.0× 10 0.3× 9 0.7× 9 0.7× 8 82
Arnaud Bayle France 7 81 1.3× 32 0.8× 21 1.6× 3 0.2× 16 160
Steffen Dörfel Germany 4 51 0.8× 13 0.3× 5 0.4× 24 1.8× 14 99
Marla Daves United States 6 37 0.6× 15 0.4× 4 0.3× 33 2.5× 9 122

Countries citing papers authored by Javier Sabater

Since Specialization
Citations

This map shows the geographic impact of Javier Sabater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Sabater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Sabater more than expected).

Fields of papers citing papers by Javier Sabater

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Sabater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Sabater. The network helps show where Javier Sabater may publish in the future.

Co-authorship network of co-authors of Javier Sabater

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Sabater. A scholar is included among the top collaborators of Javier Sabater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Sabater. Javier Sabater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Becktepe, Jos, Keltie McDonald, S. Mueller, et al.. (2025). Epidemiology and treatment patterns of essential tremor: a retrospective cohort analysis in Germany. Frontiers in Neurology. 16. 1580919–1580919.
2.
Ahuja, Arvind, Javier Sabater, Linlin Fan, et al.. (2024). 290P Global epidemiology trends in biliary tract cancer: A targeted literature review. Annals of Oncology. 35. S122–S122.
3.
Taı̈eb, Julien, Timothy Price, Fortunato Ciardiello, et al.. (2019). Health-related quality of life in the early-access phase IIIb study of trifluridine/tipiracil in pretreated metastatic colorectal cancer (mCRC): Results from PRECONNECT study.. Journal of Clinical Oncology. 37(4_suppl). 638–638. 3 indexed citations
4.
5.
6.
Tarhini, Ahmad A., Ágnes Benedict, David F. McDermott, et al.. (2018). Sequential Treatment Approaches in  the Management of BRAF Wild-Type Advanced Melanoma: A Cost–Effectiveness Analysis. Immunotherapy. 10(14). 1241–1252. 20 indexed citations
7.
8.
9.
Middleton, Mark R., et al.. (2017). Societal preferences for adjuvant melanoma health states: UK and Australia. BMC Cancer. 17(1). 689–689. 3 indexed citations
10.
11.
Beusterien, Kathleen, Mark R. Middleton, Sumati Rao, et al.. (2017). Patient and Physician Preferences for Treating Adjuvant Melanoma: A Discrete Choice Experiment. Journal of Cancer Therapy. 8(1). 37–50. 6 indexed citations
12.
Sabater, Javier, et al.. (2016). Cost-Effectiveness of Nivolumab + Ipilimumab in First-Line Treatment of Advanced Melanoma. Value in Health. 19(7). A730–A730. 1 indexed citations
13.
Thybo, Søren, et al.. (2016). Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden. Value in Health. 19(7). A730–A731. 1 indexed citations
14.
Lee, Dawn, et al.. (2016). Cost Effectiveness of Nivolumab in Combination with Ipilimumab for the Treatment of Advanced Melanoma Patients in England. Value in Health. 19(7). A731–A731. 2 indexed citations
15.
16.
17.
Budd, David C., et al.. (2015). FRI0348 Cost Comparison of Abatacept and Adalimumab Based on Ample, A 2-Year Head-to-Head Outcomes Study in Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 74. 551–552. 1 indexed citations
18.
Trautmann, Matthias, Javier Sabater, James W. Shaw, et al.. (2014). Relevance of clinical trials to inform HTA: Disparity between hta evidence requirements and published rcts in type 2 diabtetes mellitus. Value in Health. 17(3). A263–A263. 1 indexed citations
19.
Chamberlain, G., Keshwar Baboolal, Hayley Bennett, et al.. (2014). The Economic Burden of Posttransplant Events in Renal Transplant Recipients in Europe. Transplantation. 97(8). 854–861. 18 indexed citations
20.
Khanna, Dinesh, Elena Massarotti, Lisa Rosenblatt, et al.. (2013). THU0522 Comparison of Cost- Efficacy of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 72. A340–A341. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott Ramsey Breakdown of academic impact, for papers by Miriam O’Connor Breakdown of academic impact, for papers by Aneta Suder Breakdown of academic impact, for papers by Dominic Agius Breakdown of academic impact, for papers by Gracemarie Bricalli Breakdown of academic impact, for papers by Pankaj Mistry Breakdown of academic impact, for papers by Francisco J. Orlandi Breakdown of academic impact, for papers by Arnaud Bayle Breakdown of academic impact, for papers by Steffen Dörfel Breakdown of academic impact, for papers by Marla Daves
Rankless by CCL
2026